Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M102542200 on July 6, 2001

J. Biol. Chem., Vol. 276, Issue 39, 36695-36702, September 28, 2001
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/39/36695    most recent
M102542200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Faradji, R. N.
Right arrow Articles by Lipes, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Faradji, R. N.
Right arrow Articles by Lipes, M. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Glucose-induced Toxicity in Insulin-producing Pituitary Cells That Coexpress GLUT2 and Glucokinase
IMPLICATIONS FOR METABOLIC ENGINEERING*

Raquel N. FaradjiDagger §, Evis HavariDagger , Qian ChenDagger , John Gray||, Keith Tornheim**, Barbara E. Corkey**, Richard C. Mulligan||, and Myra A. LipesDagger Dagger Dagger

From the Dagger  Joslin Diabetes Center, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02215, the ** Department of Biochemistry and the Obesity Research Center, Boston University Medical Center, Boston, Massachusetts 02118, and the || Howard Hughes Medical Institute, Children's Hospital, Harvard Medical School, Boston, Massachusetts 02215

We have shown that intermediate lobe (IL) pituitary cells can be engineered to produce sufficient amounts of insulin (ins) to cure diabetes in nonobese diabetic mice but, unlike transplanted islets, ILins cells evade immune attack. To confer glucose-sensing capabilities into these cells, they were further modified with recombinant adenoviruses to express high levels of GLUT2 and the beta -cell isoform of glucokinase (GK). Although expression of GLUT2 alone had negligible effects on glucose usage and lactate production, expression of GK alone resulted in ~2-fold increase in glycolytic flux within the physiological (3-20 mM) glucose range. GLUT2/GK coexpression further increased glycolytic flux at 20 mM glucose but disproportionately increased flux at 3 mM glucose. Despite enhanced glycolytic fluxes, GLUT2/GK-coexpressing cells showed glucose dose-dependent accumulation of hexose phosphates, depletion of intracellular ATP, and severe apoptotic cell death. These studies demonstrate that glucose-sensing properties can be introduced into non-islet cells by the single expression of GK and that glucose responsiveness can be augmented by the coexpression of GLUT2. However, in the metabolic engineering of surrogate beta  cells, it is critical that the levels of the components be closely optimized to ensure their physiological function and to avoid the deleterious consequences of glucose-induced toxicity.


* This work was supported in part by the American Diabetes Association (to M. A. L.), by National Institutes of Health Grants DK35914 (to B. E. C.), DK53064 (to K. T.), and DK53281 (to M. A. L.), by the Howard Hughes Medical Institute (to R. C. M. and J. G.), and by the Juvenile Diabetes Research Foundation (JDRF) Center for Islet Transplantation at Harvard Medical School.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Recipient of a Mentor-Based JDRF Postdoctoral Research Award (to M. A. L.).

Dagger Dagger To whom correspondence should be addressed: Joslin Diabetes Center, One Joslin Place, Rm. 495, Boston, MA 02215. Tel.: 617-732-2624; Fax: 617-732-2497; E-mail: myra.lipes@joslin.harvard.edu.


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J EndocrinolHome page
K K Sidhu, R C Fowkes, R H Skelly, and J M Burrin
Exogenous expression of glucagon-like peptide 1 receptor and human insulin in AtT-20 corticotrophs confers cAMP-mediated gene transcription and insulin secretion
J. Endocrinol., December 1, 2005; 187(3): 419 - 427.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
W.-H. Kim, J. W. Lee, Y. H. Suh, S. H. Hong, J. S. Choi, J. H. Lim, J. H. Song, B. Gao, and M. H. Jung
Exposure to Chronic High Glucose Induces {beta}-Cell Apoptosis Through Decreased Interaction of Glucokinase With Mitochondria: Downregulation of Glucokinase in Pancreatic {beta}-Cells
Diabetes, September 1, 2005; 54(9): 2602 - 2611.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y.-C. Lu, C. Sternini, E. Rozengurt, and E. Zhukova
Release of Transgenic Human Insulin from Gastric G Cells: A Novel Approach for the Amelioration of Diabetes
Endocrinology, June 1, 2005; 146(6): 2610 - 2619.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
H.-i. Kim and Y.-h. Ahn
Role of Peroxisome Proliferator-Activated Receptor-{gamma} in the Glucose-Sensing Apparatus of Liver and {beta}-Cells
Diabetes, February 1, 2004; 53(90001): S60 - 65.
[Abstract] [Full Text]


Home page
DiabetesHome page
H.-i. Kim, J.-Y. Cha, S.-Y. Kim, J.-w. Kim, K. J. Roh, J.-K. Seong, N. T. Lee, K.-Y. Choi, K.-S. Kim, and Y.-h. Ahn
Peroxisomal Proliferator-Activated Receptor-{gamma} Upregulates Glucokinase Gene Expression in {beta}-Cells
Diabetes, March 1, 2002; 51(3): 676 - 685.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement